Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Radiother Oncol. 2020 Mar 27;147:8–14. doi: 10.1016/j.radonc.2020.02.022

Figure 1.

Figure 1.

The process of estimating toxicity risk using a normal tissue complication probability (NTCP) model. Green inputs are associated with the patient. Blue inputs are associated with the treatment arm and should be consistent throughout the trial.